Clinical Trial

Physical Activity and Disability Prevention in Postmenopausal Women

Study acronym: PADP-Women
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 17, 2025 (before its estimated October 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical study is to examine the impact of physical activity on the physical and mental health of postmenopausal women, with a particular focus on the development of disability. The main questions this study aims to answer are: 1. Can physical activity programs (Nordic walking, Bungy Pump, strength training, functional general conditioning training) prevent loss of mobility, bone density and urinary incontinence, reduce the risk of falls, lower metabolic syndrome parameters, and improve cardiovascular endurance in postmenopausal women? 2. Do regular exercises improve cognitive functions, motivation, memory, visual coordination, mood, and quality of life in postmenopausal women? Researchers will compare the test groups (Nordic Walking, Bungy Pump, strength training, functional general conditioning training) with the control group to determine whether physical activity brings benefits in terms of physical and mental health compared to no intervention. Participants will: Take part in a three-month physical activity program that includes Nordic walking, Bungy Pump exercises, functional general conditioning training and strength training, depending on the group. The control group will not participate in any additional physical exercise program and will continue with their usual daily activities.
Trial Details
NCT Number NCT06781541
Lead Sponsor Gdansk University of Physical Education and Sport
Collaborators: Chengdu University of Traditional Chinese Medicine
Conditions Metabolic Syndrome, Fall Risk, Sarcopenia in Elderly, Osteopenia, Osteoporosis, Cardiovascular Diseases, Dementia, Quality of Life Outcomes, Cognitive Ability, General
Enrollment 72 participants
Start Date 2022-02-21
Primary Completion 2025-10-05 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-01-17